These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19008535)

  • 1. Experimental encapsulating peritoneal sclerosis models: pathogenesis and treatment.
    Park SH; Kim YL; Lindholm B
    Perit Dial Int; 2008 Nov; 28 Suppl 5():S21-8. PubMed ID: 19008535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of peritoneal fibrosis in encapsulating peritoneal sclerosis.
    Miyazaki M; Yuzawa Y
    Perit Dial Int; 2005 Apr; 25 Suppl 4():S48-56. PubMed ID: 16300272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental animal models of encapsulating peritoneal sclerosis.
    Hoff CM
    Perit Dial Int; 2005 Apr; 25 Suppl 4():S57-66. PubMed ID: 16300273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The plasma leak-to-response hypothesis: a working hypothesis on the pathogenesis of encapsulating peritoneal sclerosis after long-term peritoneal dialysis treatment.
    Nakayama M
    Perit Dial Int; 2005 Apr; 25 Suppl 4():S71-6. PubMed ID: 16300275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New facts about encapsulating peritoneal sclerosis as a sequel of long-term peritoneal dialysis - what can we do?
    Alscher DM; Reimold F
    Minerva Urol Nefrol; 2007 Sep; 59(3):269-79. PubMed ID: 17912224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How can genetic advances impact on experimental models of encapsulating peritoneal sclerosis?
    Summers AM; Hoff CM; Topley N
    Perit Dial Int; 2008 Nov; 28 Suppl 5():S16-20. PubMed ID: 19008534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulating peritoneal sclerosis--a clinician's approach to diagnosis and medical treatment.
    Nakamoto H
    Perit Dial Int; 2005 Apr; 25 Suppl 4():S30-8. PubMed ID: 16300270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and treatment of encapsulating peritoneal sclerosis: basic and translational research.
    Schmidt DW; Flessner MF
    Perit Dial Int; 2008 Nov; 28 Suppl 5():S10-5. PubMed ID: 19008533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of gene therapy for encapsulating peritoneal sclerosis by a chimeric DNA-RNA hammerhead ribozyme targeting TGF-beta1 mRNA].
    Maruyama N; Fukuda N; Okada K; Matsumoto K
    Nihon Jinzo Gakkai Shi; 2007; 49(2):113-20. PubMed ID: 17375619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulating peritoneal sclerosis in patients on peritoneal dialysis.
    Hendriks MP; de Sévaux RG; Hilbrands LB
    Neth J Med; 2008; 66(7):269-74. PubMed ID: 18663253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A historical review of encapsulating peritoneal sclerosis.
    Kawaguchi Y; Tranaeus A
    Perit Dial Int; 2005 Apr; 25 Suppl 4():S7-13. PubMed ID: 16300267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis.
    Kawaguchi Y; Kawanishi H; Mujais S; Topley N; Oreopoulos DG
    Perit Dial Int; 2000; 20 Suppl 4():S43-55. PubMed ID: 11098928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of colchicine on the progression and regression of encapsulating peritoneal sclerosis.
    Bozkurt D; Bicak S; Sipahi S; Taskin H; Hur E; Ertilav M; Sen S; Duman S
    Perit Dial Int; 2008 Nov; 28 Suppl 5():S53-7. PubMed ID: 19008543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis.
    Bozkurt D; Cetin P; Sipahi S; Hur E; Nar H; Ertilav M; Sezak M; Duman S
    Perit Dial Int; 2008 Nov; 28 Suppl 5():S38-42. PubMed ID: 19008539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal dialysis in Japan: the issue of encapsulating peritoneal sclerosis and future challenges.
    Saito A
    Perit Dial Int; 2005 Apr; 25 Suppl 4():S77-82. PubMed ID: 16300276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New animal models for encapsulating peritoneal sclerosis--role of acidic solution.
    Nakamoto H; Imai H; Ishida Y; Yamanouchi Y; Inoue T; Okada H; Suzuki H
    Perit Dial Int; 2001; 21 Suppl 3():S349-53. PubMed ID: 11887851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of encapsulating peritoneal sclerosis: lessons from findings of the past three decades in Japan.
    Nakayama M; Miyazaki M; Hamada C; Ito Y; Honda K;
    Clin Exp Nephrol; 2023 Sep; 27(9):717-727. PubMed ID: 37278945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis and therapeutic option of encapsulating peritoneal sclerosis.
    Kawanishi H
    Int J Artif Organs; 2005 Feb; 28(2):150-5. PubMed ID: 15770603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Dutch EPS Registry: increasing the knowledge of encapsulating peritoneal sclerosis.
    Korte MR; Boeschoten EW; Betjes MG;
    Neth J Med; 2009 Sep; 67(8):359-62. PubMed ID: 19767668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of encapsulating peritoneal sclerosis in Japan.
    Kawanishi H; Moriishi M
    Perit Dial Int; 2005 Apr; 25 Suppl 4():S14-8. PubMed ID: 16300268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.